Share on StockTwits

Bioclinica (NASDAQ:BIOC) announced its earnings results on Friday. The company reported ($0.67) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.67), American Banking & Market News reports.

Shares of Bioclinica (NASDAQ:BIOC) opened at 4.651 on Friday. Bioclinica has a 1-year low of $4.16 and a 1-year high of $10.02. The stock has a 50-day moving average of $5.39 and a 200-day moving average of $6.24. The company’s market cap is $20.7 million.

On the ratings front, analysts at Aegis initiated coverage on shares of Bioclinica in a research note on Tuesday, June 3rd. They set a “buy” rating and a $16.00 price target on the stock.

BioClinica, Inc, formerly Bio-Imaging Technologies, Inc, provides integrated clinical research services, including imaging core lab and eClinical technologies and services to pharmaceutical, biotechnology, and medical device companies, and other organizations, such as contract research organizations (NASDAQ:BIOC), engaged in global clinical studies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.